Analyst Ratings for TG Therapeutics
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for TG Therapeutics (NASDAQ:TGTX) in the last quarter, with 5 bullish ratings and 1 bearish rating. The company has an average price target of $32.92, which has increased by 54.34% over the past month.
July 24, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have provided bullish ratings for TG Therapeutics, indicating a positive outlook for the company's stock.
The bullish ratings from analysts indicate a positive outlook for TG Therapeutics. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100